Stocks › WRBY
Warby Parker Inc.
WRBY·NYSE·
United States·USD
United States·USD$26.23
-0.42 (-1.58%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
WRBY
Warby Parker Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
WRBYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of WRBY by members of U.S. Congress · 0 on record
No congressional trades in WRBY on record.
Whale Activity
Position changes in WRBY reported for 2026-06-30 by 12 tracked institutional filers
- Increased5
- New0
- Held0
- Decreased3
- Closed2
- No prior filing2
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 15.3M | $464.5M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.0M | $181.5M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $136.1M | increased |
| MILLENNIUM MANAGEMENT LLC | 828.8K | $25.1M | increased |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 587.7K | $17.8M | — |
| Point72 Asset Management, L.P. | 336.1K | $10.2M | increased |
| CITADEL ADVISORS LLC | 334.2K | $10.1M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 209.3K | $6.4M | decreased |
| Atika Capital Management LLC | 150.0K | $4.6M | — |
| TWO SIGMA INVESTMENTS, LP | 55.3K | $1.7M | decreased |
| Bridgewater Associates | 0 | $0 | closed |
| D. E. Shaw & Co., Inc. | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by WRBY insiders, by quarter · Form 4
Recent Insider Transactions
709 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Raider Jeffrey JacobDirector · Director | Sale | −15.0K | $27.70 | $416K | Oct 1, 2026 | Form 4 ↗ |
| Blumenthal Neil HarrisCo-Chief Executive Officer · Director | Sale | −100.0K | $27.69 | $2.8M | Oct 1, 2026 | Form 4 ↗ |
| Gilboa David AbrahamCo-Chief Executive Officer · Director | Sale | −54.3K | $29.84 | $1.6M | Jul 6, 2026 | Form 4 ↗ |
| Blumenthal Neil HarrisCo-Chief Executive Officer · Director | Sale | −9,200 | $29.99 | $276K | Jul 6, 2026 | Form 4 ↗ |
| Raider Jeffrey JacobDirector · Director | Sale | −22.5K | $29.72 | $669K | Jul 1, 2026 | Form 4 ↗ |
| Gilboa David AbrahamCo-Chief Executive Officer · Director | Sale | −242.2K | $29.69 | $7.2M | Jul 1, 2026 | Form 4 ↗ |
| Blumenthal Neil HarrisCo-Chief Executive Officer · Director | Sale | −217.7K | $29.61 | $6.4M | Jul 1, 2026 | Form 4 ↗ |
| Blumenthal Neil HarrisCo-Chief Executive Officer · Director | Sale | −36.3K | $30.04 | $1.1M | Jun 29, 2026 | Form 4 ↗ |
| Briggs TeresaDirector | Sale | −1,908 | $26.79 | $51K | Jun 16, 2026 | Form 4 ↗ |
| Briggs TeresaDirector | Sale | −3,092 | $25.41 | $79K | Jun 16, 2026 | Form 4 ↗ |
| Moon Youngme EDirector | Sale | −10.0K | $26.53 | $265K | Jun 12, 2026 | Form 4 ↗ |
| Raider Jeffrey JacobDirector | Grant / award | +9,004 | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| Hunt AndrewDirector | Grant / award | +12.0K | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| Briggs TeresaDirector | Grant / award | +9,004 | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| Moon Youngme EDirector | Grant / award | +9,004 | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| WILLIAMS RONALD ADirector | Grant / award | +13.0K | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| SINGER BRADLEY EDirector | Grant / award | +9,004 | $0.00 | $0 | Jun 8, 2026 | Form 4 ↗ |
| Gilboa David AbrahamCo-Chief Executive Officer · Director | Tax withholding | −11.5K | $24.38 | $280K | Jun 2, 2026 | Form 4 ↗ |
| Gilboa David AbrahamCo-Chief Executive Officer · Director | Option exercise | +11.0K | $0.00 | $0 | Jun 2, 2026 | Form 4 ↗ |
| Gilboa David AbrahamCo-Chief Executive Officer · Director | Option exercise | +9,816 | $0.00 | $0 | Jun 2, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding WRBY · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 6.1M | $184.0M | 0.17% | Jun 30, 2026 |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 4.6M | $122.9M | 0.12% | Jul 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.2M | $97.9M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.7M | $81.7M | 0.10% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.3M | $70.7M | 0.04% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH Capitol Series Trust | 1.6M | $47.3M | 0.77% | Jun 30, 2026 |
| SMALLCAP World Fund Inc | 1.4M | $41.4M | 0.04% | Jun 30, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $40.9M | 0.09% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1.5M | $38.8M | 0.44% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.2M | $35.1M | 0.04% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list WRBY's shares (CUSIP 93403J106), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming warby parker as client
No lobbying filings found naming Warby Parker Inc. as the client.
- ARNOLD & PORTER KAYE SCHOLER LLPWARBY PARKER · 2018 Q2—
Filing ↗ - ARNOLD & PORTER KAYE SCHOLER LLPWARBY PARKER · 2018 Q1—
Filing ↗ - ARNOLD & PORTER KAYE SCHOLER LLPWARBY PARKER · 2017 Q4 · HCR, CSP—
Filing ↗ - ARNOLD & PORTER KAYE SCHOLER LLPWARBY PARKER · 2017 Q3 · HCR, CSP—
Filing ↗ - ARNOLD & PORTER KAYE SCHOLER LLPWARBY PARKER · 2017 Q2 · HCR, CSP$10K
Filing ↗
Government Contracts
Federal awards to Warby Parker Inc. · USAspending
No federal contract awards found for Warby Parker Inc..
U.S. Patents
Recent USPTO applications naming Warby Parker Inc.
No USPTO patent applications found for Warby Parker Inc..
Annual Financials
From WRBY's 10-K filings · XBRL
No annual XBRL figures on record for WRBY. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in WRBY's price history.
About Warby Parker Inc.
From SEC EDGAR company records
Industry (SIC 3851)Ophthalmic Goods
SectorHealthcare
HeadquartersNEW YORK, NY
IncorporatedDE
SEC CIK0001504776 ↗
Former namesJAND, Inc.